Robin J Parks

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Circulating Tumor

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer gene therapy

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua Del Papa, Ryan G Clarkin, Robin J Parks
Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic. Cancer gene therapy 28 (7-8) (2020)
Kathy L Poulin, Emily R McFall, Grace Chan, Natacha B Provost, Carin Christou, Adam C Smith, Robin J Parks
Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity. Journal of virology 94 (17) (2020)
Robin J Parks, Emanuela Gussoni
Building immune tolerance through DNA vaccination. Proceedings of the National Academy of Sciences of the United States of America 115 (39) (2018)
Bratati Saha, Robin J Parks
Human adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells. PloS one 12 (7) (2017)
Walaa Eid, Kristin Dauner, Kevin C Courtney, AnneMarie Gagnon, Robin J Parks, Alexander Sorisky, Xiaohui Zha
mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 114 (30) (2017)